LCE reports on lymphomas and CLL in Europe are based on current information from LC Global database on access to treatments and clinical trials, and on LC biennial survey on the patient experience. This information is developed to be used by patient organisations as a tool to support and enhance their advocacy and awareness raising capacities.
The European Lymphoma Environment report illustrates the inequalities of access to care – medicines, treatments centers, clinical trials, etc. - around Europe, identifying patients’ unmet needs and highlighting the main issues and obstacles European patients experience all along their journey. An updated version of this report will be published in September 2017.
The CLL European report is the first LCE report focusing on a specific lymphoma subtype. The objective is to help our member organisations better understand the biology of the disease and the treatment options available, as well as to evidence the specific unmet needs of CLL patient in Europe in terms of therapy access, clinical trials and quality of life.